A PSA-activated protoxin (PRX302) administered transperineally to men with BPH is well tolerated and induces reduction in prostate volume and symptomatic relief

Abi-Habib, Ralph J.; Pommerville, Peter J.; Steinhoff, Gary

dc.contributor.author	Abi-Habib, Ralph J.
dc.contributor.author	Pommerville, Peter J.
dc.contributor.author	Steinhoff, Gary
dc.date.accessioned	2018-06-13T09:40:28Z
dc.date.available	2018-06-13T09:40:28Z
dc.date.copyright	2009	en_US
dc.date.issued	2018-06-13
dc.identifier.issn	1527-3792	en_US
dc.identifier.uri	http://hdl.handle.net/10725/8038
dc.language.iso	en	en_US
dc.title	A PSA-activated protoxin (PRX302) administered transperineally to men with BPH is well tolerated and induces reduction in prostate volume and symptomatic relief	en_US
dc.type	Article	en_US
dc.description.version	Published	en_US
dc.author.school	SAS	en_US
dc.author.idnumber	200901419	en_US
dc.author.department	Natural Sciences	en_US
dc.description.embargo	N/A	en_US
dc.relation.journal	The journal of Urology	en_US
dc.journal.volume	181	en_US
dc.journal.issue	4	en_US
dc.article.pages	704	en_US
dc.identifier.ctation	Pommerville, P. J., Steinhoff, G., Denmeade, S., Merchant, R., Buckley, T., & Abi-Habib, R. J. (2009). A PSA-ACTIVATED PROTOXIN (PRX302) ADMINISTERED TRANSPERINEALLY TO MEN WITH BPH IS WELL TOLERATED AND INDUCES REDUCTION IN PROSTATE VOLUME AND SYMPTOMATIC RELIEF. The Journal of Urology, 181(4), 704.	en_US
dc.author.email	ralph.abihabib@lau.edu.lb	en_US
dc.identifier.tou	http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php	en_US
dc.identifier.url	https://www-clinicalkey-com.ezproxy.lau.edu.lb:2443/service/content/pdf/watermarked/1-s2.0-S0022534709619686.pdf?locale=en_US	en_US
dc.author.affiliation	Lebanese American University	en_US